Bill113th Congress

H.R. 1915

GEDI Act

Ask AI
Introduced
May 9, 2013
Origin Chamber
House
Policy Area
Health
Latest Action
May 10, 2013
Latest Action

Referred to the Subcommittee on Health.

Sponsor

Rep. Engel, Eliot L. [D-NY-16]

Democrat·NY-16
First Name: ELIOT
Middle Name: L.
Last Name: ENGEL
By Request: N
44
Cosponsors
1
Committees
4
Actions
0
Amendments
1
Related Bills
9
Subjects
1
Summaries
4
Titles
1
Text Versions

Bill Details

Update Date
Nov 15, 2022
Origin Chamber
House
Bill Type
HR
Bill Number
1,915
Congress
113
Introduced Date
May 9, 2013
Policy Area
Health
Is Law
No
May 10, 2013Committee

Referred to the Subcommittee on Health.

Source: House committee actions

May 9, 2013IntroReferralH11100

Referred to the House Committee on Energy and Commerce.

Source: House floor actions

May 9, 2013IntroReferralIntro-H

Introduced in House

Source: Library of Congress

May 9, 2013IntroReferral1000

Introduced in House

Source: Library of Congress

Introduced in House· May 9, 20130

Gestational Diabetes Act of 2013 or the GEDI Act - Amends the Public Health Service Act to direct the Director of the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes research project within the diabetes program of the CDC to expand and enhance surveillance data and public health research on gestational diabetes. 

Requires the Secretary of Health and Human Services (HHS) to expand and intensify public health research on gestational diabetes, including; (1) developing and testing novel approaches for improving postpartum testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes, and (2) conducting research to further understanding of the factors and health systems that influence the risk of gestational diabetes and the development of type 2 diabetes in women with a history of gestational diabetes.

Requires the Director to: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and Indian tribal-based diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.

Energy and Commerce Committee

House· Standing
Advisory bodiesDigestive and metabolic diseasesHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsSex and reproductive healthWomen's health

Introduced in House

May 9, 2013

VIEW
GEDI Act — Informed